HMOX1 and renal cell carcinoma: Luteolin demonstrates an anticancer effect on clear renal cell carcinoma by upregulating heme oxygenase-1 (HO-1) expression and activating labile iron pool (LIP)directly, thus triggering ferroptosis (Han et al., 2022b).